Incidence of anti-Helicobacter pylori and anti-CagA antibodies in rosacea patients

International Journal of Dermatology

Volumn 42, Issue 8, 2003, Pages 601-604

  Argenziano, Gabriele ^a   Donnarumma, Giovanna ^a   Iovene, Maria Rosaria ^a   Arnese, Pietro ^a   Baldassarre, Maria Assunta ^a   Baroni, Adone ^a  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; CAGA ANTIBODY; HELICOBACTER PYLORI ANTIBODY; IMMUNOGLOBULIN; IMMUNOGLOBULIN A ANTIBODY; NONSTEROID ANTIINFLAMMATORY AGENT; UNCLASSIFIED DRUG;

ADULT; AGED; ANTIBODY DETECTION; CLINICAL ARTICLE; CONFERENCE PAPER; CORRELATION ANALYSIS; DIGESTIVE SYSTEM ULCER; DYSPEPSIA; ENZYME IMMUNOASSAY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GASTROINTESTINAL SYMPTOM; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HUMAN; IMMUNOGLOBULIN BLOOD LEVEL; MALE; NONHUMAN; PREVALENCE; ROSACEA; SKIN LUPUS ERYTHEMATOSUS;

ADULT; AGED; ANTIBODIES, ANTI-IDIOTYPIC; ANTIGENS, BACTERIAL; BACTERIAL PROTEINS; DYSPEPSIA; FEMALE; HELICOBACTER PYLORI; HUMANS; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; MALE; MIDDLE AGED; ROSACEA;

EID: 0042889251     PISSN: 00119059     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-4362.2003.01817.x     Document Type: Article

References (24)

1. Forton F, Seys B. Density of Demodex folliculorum in rosacea: A case-control study using standardized biopsy. Br J Dermatol 1993; 128: 50-59.
2. Gerra L, Tosti A. La dermatite seborroica. Dermotime 1990; 3: 15.
3. Di Campli C, Gasbarrini A, Numera E, et al. Beneficial effects of Helicobacter pylori eradication on idiopathic chronic urticaria. Dig Dis Sci 1998; 43: 1226-1229.
4. Gasbarrini A, Franceschi F, Gasbarrini G, et al. Extraintestinal pathology associated with Helicobacter infection. Eur J Gastroenterol Hepatol 1997; 9: 231-233.
5. Gasbarrini A, Serricchio M, Tondi P, et al. Association of Helicobacter pylori infection with primary Raynaud phenomenon. Lancet 1996; 348: 966-967.
6. Leontiadis GI, Sharma WK, Howden CW. Non-gastrointestinal tract associations of Helicobacter pylori infection. Arch Intern Med 1999; 159: 925-940.
7. Realdi G, Dore MP, Fastame L. Extradigestive manifestations of Helicobacter pylori infection. Fact Fiction Dig Dis Sci 1999; 44: 229-236.
8. Rebora A, Drago F, Picciotto A. Helicobacter pylori in patients with rosacea. (Letter). 1994; 89: 1603-1614.
9. Rebora A, Drago F, Parodi A. May Helicobacter pylori be important for dermatologist? Dermatology 1995; 191: 6-8.
10. Sharma VK, Lynn A, Karminski M, et al. A study of the prevalence of Helicobacter pylori infection and other gastrointestinal tract disease in patients with rosacea. Am J Gastroenterol 1998; 93: 220-222.
11. Grilli R. Helicobacter pylori: Related to rosacea. Am Acad Dermatol 2000; 42: 536-547
12. Rebora A, Drago E. Helicobacter pylori and rosacea. Am Acad Dermatol 2000; 43: 884.
13. Jones MP, Knable AL, White MJ, Durning SJ. Helicobacter pylori in rosacea: Lack of an association. Arch Dermatol 1998; 134: 511-516.
14. Kolibasova K, Tothova I, Baumgartner J, Filo V. Eradication of Helicobacter pylori as the only successful treatment in rosacea. Arch Dermatol 1996; 132 (1397): 1393.
15. Bamford JT, Tilden RL, Blankush J, Gaugeness DE. Effect of treatment of Helicobacter pylori infection on rosacea. Arch Dermatol 1999; 135: 659-663.
16. Baumford JT, Tilden RL, Gaugeness DE. Does Helicobacter pylori eradication treatment reduce the severity of rosacea? J Am Acad Dermatol 2000; 42: 535-546.
17. Drago F, Caratti F, Picciotto A, et al. Helicobacter pylori is a common isolate bacterium in the stomach of rosacea patients. G Ital Dermatol Venereol 1995; 130: 113-115.
18. Powell FC, Daw MA, Duguid C. Positive Hp serology in rosacea patients. Workshop Gastroduodenal Pathology Helicobacter Pylori 1993; V: 76.
19. Schneider MA, Sidnner RB, Rosemberg EW Jr., et al. Serologic determination of Helicobacter pylori in rosacea patients and controls. Clin Res 1992; 40: 831-835.
20. Herr H, You CH. Relationship between Helicobacter pylori and rosacea: It may be a myth. J Korean Med Sci 2000; 15: 551-554.
21. Shiotani A, Okada K, Yanaoka K, et al. Beneficial effect of Helicobacter pylori eradication in dermatologic diseases. Helicobacter 2001; 6: 60-665.
22. Censini S, Lange C, Xiang Z, et al. Cag A patogenecity island of Helicobacter pylori, encoded type I-specific and disease-associated virulence factors. Proceedings Natl Acad Sci USA, 1996; 93: 14648-14653.
23. Peek RM, Miller GG. Heightened cytokine expression and inflammation response in vivo to CagA+ Helicobacter pylori strains. Laboratory Invest 1995; 73: 760-764.
24. Macchia G, Massone A, Burroni D, et al. The hsp 60′ protein of Helicobacter pylori: Structure and immune response in patients with gastroduodenal diseases. Mol Microbiol 1993; 9: 645-652.